insights_auto
Waarom is EVT gedaald 5,12%?
Meer informatiechevron_right
EVT:FRA
Evotec
€ 2,93
arrow_downward
-5,12%(-0,16) 1D
2 okt, 19:46:41 GMT+2 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor EVT genereren…
Openen
€ 3,00
Hoog
€ 3,09
Laag
€ 2,90
Beursw.
511,78Â mln.
Gem. vol.
4,46K
Volume
1,55K
52 wk hoog
€ 7,49
52 wk laag
€ 2,73
WPA
€ -1,11
Uitstaande aandelen
148,72Â mln.
Aantal medewerkers
4K
Openen
€ 3,00
Hoog
€ 3,09
Laag
€ 2,90
Beursw.
511,78Â mln.
Gem. vol.
4,46K
Volume
1,55K
52 wk hoog
€ 7,49
52 wk laag
€ 2,73
WPA
€ -1,11
Uitstaande aandelen
148,72Â mln.
Aantal medewerkers
4K
Nieuwsartikelen
Van webbronnen en nieuwspartners
AD HOC NEWS
·
1 uur geleden
Evotec stock after-hours at EUR 2.92: minus 4.26 percent
AD HOC NEWS
·
3 uur geleden
Evotec announces science chief exit and Evotec stock falls 3.93 percent
TipRanks
·
3 dagen geleden
Evotec SE Announces Chief Scientific Officer Transition as Long-Serving CSO Steps Down
AD HOC NEWS
·
3 dagen geleden
Evotec stock gains 2.45 percent as chief scientist exits
Profiel
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
Over Evotec